Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)
13.53
+0.35 (2.66%)
Apr 29, 2025, 2:45 PM CST
SHE:002603 Revenue
Shijiazhuang Yiling Pharmaceutical had revenue of 2.36B CNY in the quarter ending March 31, 2025, with 35.25% growth. This brings the company's revenue in the last twelve months to 8.11B, down -38.39% year-over-year. In the year 2023, Shijiazhuang Yiling Pharmaceutical had annual revenue of 10.32B, down -17.67%.
Revenue (ttm)
8.11B
Revenue Growth
-38.39%
P/S Ratio
2.79
Revenue / Employee
580.96K
Employees
13,958
Market Cap
22.59B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 10.32B | -2.21B | -17.67% |
Jan 1, 2023 | 12.53B | 2.42B | 23.88% |
Jan 1, 2022 | 10.12B | 1.33B | 15.19% |
Dec 31, 2020 | 8.78B | 2.96B | 50.76% |
Dec 31, 2019 | 5.83B | 1.01B | 20.99% |
Jan 1, 2019 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.79B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.30B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |